Highlights Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
63.21 ^USD	-2.02%		-0.75%	-18.08%

Apr. 30	Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	CI
Apr. 29	Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	Apr. 29	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	Apr. 29	CI
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	Apr. 26	CI
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	Apr. 23	MT
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	Mar. 28	MT
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	Mar. 22	MT
Ex-dividend day	Feb. 08	FA
Bio-Techne Seeks M&A	Feb. 01	CI
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	Feb. 01	MT
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	Feb. 01	MT
Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01	CI
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended December 31, 2023, Payable February 26, 2024	Feb. 01	CI
North American Morning Briefing : Stock Futures -2-	Feb. 01	DJ
Bio-Techne Corporation Sets New Standard with the Development of A Next-Generation, Protease-Free RNAscope Spatial Multiomics Workflow	Jan. 29	CI
Bio-Techne Files Drug Master File With US FDA for ExCellerate GMP for Stem Cell Therapy	Dec. 20	MT
Ex-dividend day	Nov. 08	FA
Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1, 2022.	Nov. 07	CI
Bio-Techne's Fiscal Q1 Adjusted Earnings Decline, Net Sales Rise	23-10-31	MT
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q1 Revenue $276.9M	23-10-31	MT
Bio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	23-10-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Techne Corporation

Equities

TECH

US09073M1045

Highlights

Filters